GO:2000779 regulation of double-strand break repair: Pathway Choice, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:2000779 (regulation of double-strand break repair) is a biological process that modulates the frequency, rate or extent of double-strand break (DSB) repair, thereby determining genome stability.
• The central decision in DSB repair is pathway choice between error-free homologous recombination (HR) and error-prone non-homologous end joining (NHEJ), controlled by DNA end resection, cell-cycle phase and chromatin signals.
• Post-translational modifications, especially ubiquitination and ubiquitin-like modifiers, provide the regulatory code that recruits repair factors to DSB sites.
• Deubiquitinating enzymes (DUBs) counteract ubiquitin signals and are emerging as critical regulators of DSB repair efficiency and pathway selection.
• Noncoding RNAs and mitotic kinases such as PLK1 add additional layers of regulation, including polymerase theta (Polθ)-mediated repair in mitosis.
• Deregulation of DSB repair regulation drives cancer, neurodegeneration and genome instability, making it a major therapeutic target.
Description
Double-strand breaks (DSBs) are among the most cytotoxic DNA lesions, and their repair is essential for cell survival and genome integrity. The biological process GO:2000779, regulation of double-strand break repair, encompasses any process that modulates the frequency, rate or extent of DSB repair. This regulatory layer determines not only whether a break is repaired, but also which repair pathway is used, with profound consequences for mutation load and genome evolution. Understanding GO:2000779 is therefore central to cancer biology, aging research and the development of precision genome-editing tools. The regulation of DSB repair operates through DNA end resection, cell-cycle checkpoints, post-translational modifications and chromatin remodeling. Because pathway choice is a decisive event, researchers study the regulators that tip the balance between homologous recombination (HR) and non-homologous end joining (NHEJ). This article synthesizes the authoritative QuickGO definition with real PubMed literature to provide a research-grade overview of GO:2000779, its key genes and the experimental methods used to interrogate it.
regulation of double-strand break repair At A Glance
| GO ID | GO:2000779 |
|---|---|
| GO term | regulation of double-strand break repair |
| Ontology | biological_process |
| Synonym | none |
| Major function | Modulates the frequency, rate or extent of double-strand break repair, including pathway choice between HR and NHEJ |
| Key regulatory layer | Ubiquitin and ubiquitin-like modifications that recruit repair factors to DSB sites |
| Cell-cycle dependency | Pathway choice is strongly influenced by cell-cycle phase and DNA end resection |
| Disease relevance | Deregulation is linked to cancer, genome instability and error-prone repair |
What Is GO:2000779?
GO:2000779 is defined by QuickGO as any process that modulates the frequency, rate or extent of double-strand break repair. In practice, this means the term covers all molecular and cellular events that influence how often, how quickly or how completely a DSB is repaired, including the signaling cascades, protein modifications and pathway-choice decisions that regulate repair.
Why Is regulation of double-strand break repair Important in Cell Biology?
Regulation of double-strand break repair is important because it determines whether a cell survives a DSB with high fidelity or accumulates mutations, deletions and chromosomal rearrangements. Because DSBs are induced by ionizing radiation, chemotherapy and endogenous replication stress, the regulatory networks that control their repair are directly relevant to cancer therapy and genome editing. Moreover, the same regulators influence the balance between error-free HR and error-prone NHEJ, shaping genome evolution and the mutational landscapes of tumors.
• Determines pathway choice between error-free HR and error-prone NHEJ, directly affecting mutation load.
• Controls genome stability and prevents chromosomal rearrangements.
• Influences sensitivity to radiotherapy and DNA-damaging chemotherapy.
• Ubiquitin and ubiquitin-like modifiers provide reversible switches that recruit repair proteins.
• Deubiquitinating enzymes fine-tune repair factor stability and localization.
• Noncoding RNAs add an additional regulatory layer at DSB sites.
• Mitotic kinases such as PLK1 regulate Polθ-dependent repair in mitosis.
• Deregulation is implicated in cancer, neurodegeneration and premature aging.
• Provides targets for synthetic lethality strategies in HR-deficient tumors.
• Informs the design of safer and more efficient CRISPR genome-editing experiments.
What Happens During regulation of double-strand break repair?
DSB sensing and checkpoint activation
In simple terms: The cell first detects a broken DNA end and sounds an alarm that pauses the cell cycle.
Upon DSB formation, sensor complexes recognize the break and activate checkpoint signaling that coordinates repair with cell-cycle progression. This sensing step is a prerequisite for the regulatory events that define GO:2000779, because it determines whether repair proceeds and which pathway is engaged. The regulatory network includes post-translational modifications that mark the chromatin surrounding the break.
DNA end resection and pathway choice
In simple terms: The cell trims the broken DNA ends, and how much it trims helps decide which repair method is used.
DNA end resection is the decisive regulatory step that commits a DSB to homologous recombination rather than non-homologous end joining. Resection generates single-stranded DNA that is bound by RPA and subsequently by RAD51, promoting HR. Regulation of resection therefore directly modulates the frequency and extent of DSB repair, which is the essence of GO:2000779.
Ubiquitin and ubiquitin-like modification signaling
In simple terms: Small tags are attached to proteins at the break site to call in the right repair tools.
Ubiquitination and ubiquitin-like modifications such as SUMOylation regulate the recruitment, retention and activity of DSB repair factors. These reversible modifications provide a dynamic regulatory code that influences pathway choice and repair efficiency. Deubiquitinating enzymes remove these tags and thereby fine-tune the repair response.
Noncoding RNA and mitotic regulation
In simple terms: RNA molecules and cell-division kinases add extra control over how breaks are fixed.
Noncoding RNAs have been shown to participate in the regulation of DSB repair, contributing to the recruitment of repair factors and to pathway selection. In mitosis, PLK1 phosphorylates Polθ to promote DSB repair, illustrating how cell-cycle kinases regulate repair outside of canonical HR and NHEJ. These layers expand the regulatory scope of GO:2000779 beyond protein-centric models.
Error-prone repair and genome evolution
In simple terms: When regulation fails, the cell may use sloppy repair that causes mutations.
Regulation of DSB repair also controls the extent to which error-prone pathways are used, with direct consequences for genome evolution. When regulatory checkpoints are compromised, error-prone repair can dominate and generate mutations and rearrangements. This link between regulation and mutagenesis is a major reason GO:2000779 is studied in cancer and evolution.
Key Genes Involved in GO:2000779 regulation of double-strand break repair
The following genes and proteins are central to the regulation of double-strand break repair and are commonly studied in this context.
| Gene | Major Role | Research Relevance |
|---|---|---|
| ATM | DSB sensor kinase that initiates checkpoint signaling | Central regulator of DSB repair pathway choice |
| BRCA1 | Promotes DNA end resection and homologous recombination | Key determinant of HR versus NHEJ |
| BRCA2 | Loads RAD51 onto single-stranded DNA during HR | Frequently studied in HR-deficient tumors |
| RAD51 | Catalyzes homologous recombination strand invasion | Core HR effector and pathway marker |
| TP53BP1 | Promotes NHEJ and limits resection | Antagonist of BRCA1 in pathway choice |
| MRE11 | Part of the MRN complex involved in end resection | Regulates resection initiation |
| RAD50 | MRN complex component for DSB sensing and resection | Links sensing to resection |
| NBN | Nibrin, MRN component in DSB response | Mutations cause Nijmegen breakage syndrome |
| PLK1 | Mitotic kinase that phosphorylates Polθ | Regulates mitotic DSB repair |
| POLQ | Polymerase theta mediating alternative end joining | Target of PLK1 regulation in mitosis |
| USP1 | Deubiquitinating enzyme acting on repair factors | Regulates repair factor stability |
| USP7 | Deubiquitinating enzyme involved in DSB repair | Modulates repair protein turnover |
| SUMO1 | Ubiquitin-like modifier conjugated to repair proteins | Regulates repair factor recruitment |
| UBE2D1 | E2 ubiquitin-conjugating enzyme in DSB signaling | Ubiquitin cascade component |
| RNF8 | E3 ubiquitin ligase recruited to DSB sites | Ubiquitin signaling at breaks |
| RNF168 | E3 ubiquitin ligase amplifying ubiquitin signals | Chromatin ubiquitination for repair |
| DICER | Noncoding RNA processing factor | Linked to noncoding RNA regulation of DSB repair |
How Is regulation of double-strand break repair Regulated?
Regulation of double-strand break repair is itself controlled by cell-cycle phase, checkpoint kinases and post-translational modifications. Ubiquitin and ubiquitin-like modifiers provide reversible switches that recruit and retain repair factors at DSB sites, while deubiquitinating enzymes remove these marks to fine-tune the response. Noncoding RNAs and mitotic kinases such as PLK1 add further regulatory layers, including Polθ-dependent repair in mitosis. Together, these mechanisms ensure that DSB repair is coordinated with cell-cycle progression and genome integrity.
regulation of double-strand break repair and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| BRCA1 | Hereditary breast and ovarian cancer | BRCA1 knockout cell line for HR deficiency |
| BRCA2 | Fanconi anemia and breast cancer | BRCA2 point-mutation knock-in model |
| ATM | Ataxia-telangiectasia | ATM knockout for checkpoint studies |
| NBN | Nijmegen breakage syndrome | NBN knockout for MRN function |
| POLQ | Alternative end joining in cancer | POLQ knockout for mitotic repair |
Cancer and genome instability
Deregulation of DSB repair pathway choice is a hallmark of many cancers, where error-prone repair and loss of HR drive mutation accumulation and chromosomal rearrangements. Defects in BRCA1, BRCA2 or other HR regulators create synthetic lethal vulnerabilities that are exploited therapeutically. Because GO:2000779 controls the frequency and fidelity of repair, its components are attractive targets in oncology.
Neurodegeneration and aging
Neurons are particularly sensitive to DSBs, and impaired regulation of DSB repair has been linked to neurodegeneration and aging-related genome instability. When regulatory checkpoints fail, error-prone repair can contribute to neuronal dysfunction. This connection makes GO:2000779 relevant to neurodegenerative disease research.
Inherited repair-deficiency syndromes
Mutations in DSB repair regulators such as ATM and NBN cause inherited syndromes characterized by genome instability and cancer predisposition. These disorders illustrate how critical the regulation of DSB repair is for human health. Studying GO:2000779 helps explain the molecular basis of these syndromes.
From regulation of double-strand break repair-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of a candidate regulator alter HR efficiency? | Knockout cell line with HR reporter |
| Does a specific residue control pathway choice? | Point-mutation knock-in of the residue |
| Where does a repair protein localize after DSBs? | Tagged knock-in with fluorescent tag |
| Does overexpression of a regulator shift pathway balance? | Overexpression cell model |
| Which genes modify sensitivity to DSB-inducing agents? | CRISPR library screening |
| What is the transcriptomic response to DSB induction? | RNA-seq after irradiation |
How to Study the regulation of double-strand break repair Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Comet assay | DSB induction and repair kinetics | Quantifying repair capacity |
| HR/NHEJ reporter assay | Pathway-specific repair efficiency | Pathway choice studies |
| Immunofluorescence foci | Recruitment of repair factors | Spatiotemporal regulation |
| Mass spectrometry | Ubiquitination and SUMOylation of repair proteins | Post-translational regulation |
| RNA-seq | Transcriptional response to DSBs | Regulatory network discovery |
| Small RNA sequencing | Noncoding RNA changes after DSBs | Noncoding RNA regulation |
| CRISPR library screening | Genes modifying DSB sensitivity | Functional genomics |
| Live-cell imaging | Real-time repair factor dynamics | Kinetics of repair |
DSB induction and repair assays
Researchers induce DSBs with ionizing radiation or site-specific nucleases and measure repair kinetics using comet assays, pulsed-field gel electrophoresis or reporter-based assays. These methods quantify the frequency and rate of repair, directly reflecting GO:2000779 activity. Combining them with pathway-specific inhibitors helps resolve HR versus NHEJ contributions.
Imaging of repair foci
Fluorescence microscopy of repair foci such as RAD51, 53BP1 and γH2AX provides spatial and temporal information about DSB repair regulation. Live-cell imaging of tagged proteins allows tracking of repair factor recruitment. These approaches are essential for linking regulatory events to repair outcomes.
Proteomics and post-translational modification analysis
Mass spectrometry-based proteomics can identify ubiquitination and SUMOylation events on repair factors, revealing the regulatory code at DSB sites. Deubiquitinating enzyme substrates can be mapped to understand how ubiquitin signals are reversed. These methods connect GO:2000779 to specific molecular modifications.
Transcriptomics and noncoding RNA profiling
RNA-seq and small RNA sequencing can reveal changes in gene expression and noncoding RNA levels after DSB induction. Such data help identify regulatory networks that modulate DSB repair. Integrating transcriptomics with repair assays provides a systems-level view of GO:2000779.
How CRISPR Can Be Used to Study GO:2000779 regulation of double-strand break repair
Knockout
CRISPR knockout of candidate regulators is used to test whether a gene is required for DSB repair and pathway choice. Knockout cell lines can be challenged with DSB-inducing agents to measure repair efficiency and sensitivity. This approach is foundational for assigning function within GO:2000779.
Point Mutation
Point-mutation knock-in allows precise testing of phosphorylation, ubiquitination or other modification sites on repair regulators. For example, mutating a PLK1 phosphorylation site on Polθ can reveal its role in mitotic repair. Such models dissect mechanism without confounding effects of whole-gene loss.
Knock-in
Tagged knock-in of repair proteins enables visualization and interaction studies in a physiological context. Fluorescent or affinity tags can be introduced at endogenous loci to track recruitment to DSB sites. This is valuable for studying the dynamic regulation of DSB repair.
Overexpression
Overexpression models test whether increased levels of a regulator are sufficient to shift pathway choice or enhance repair. They are useful for gain-of-function studies and for validating regulatory hypotheses. Combined with knockout data, overexpression provides bidirectional evidence for gene function in GO:2000779.
How EDITGENE Supports regulation of double-strand break repair Research
Researchers studying regulation of double-strand break repair-related genes often need to determine whether a candidate gene is causally involved in pathway choice, repair efficiency or genome stability. EDITGENE provides CRISPR-based cell model services that enable precise, reproducible interrogation of GO:2000779 components.
Contact EDITGENE today to design your custom CRISPR model for regulation of double-strand break repair research.
Frequently Asked Questions About regulation of double-strand break repair
What is GO:2000779?
GO:2000779 is the Gene Ontology term for regulation of double-strand break repair, defined as any process that modulates the frequency, rate or extent of double-strand break repair.
What genes are involved in regulation of double-strand break repair?
Key genes include ATM, BRCA1, BRCA2, RAD51, TP53BP1, MRE11, RAD50, NBN, PLK1, POLQ and several ubiquitin-related factors.
How does the cell decide between HR and NHEJ?
DNA end resection, cell-cycle phase and regulatory modifications determine whether a DSB is repaired by homologous recombination or non-homologous end joining.
What role do ubiquitin-like modifiers play in DSB repair?
Ubiquitin and ubiquitin-like modifiers such as SUMO regulate the recruitment and activity of repair factors at DSB sites.
How are deubiquitinating enzymes involved in DSB repair?
Deubiquitinating enzymes remove ubiquitin from repair factors, fine-tuning their stability and localization during DSB repair.
Do noncoding RNAs regulate double-strand break repair?
Yes, noncoding RNAs have been implicated in the regulation of DSB repair and repair factor recruitment.
How is Polθ regulated during mitosis?
PLK1 phosphorylates Polθ to promote DSB repair in mitosis.
Why is regulation of DSB repair important in cancer?
Deregulated DSB repair drives genome instability and is exploited for synthetic lethality in HR-deficient tumors.
What methods are used to study DSB repair regulation?
Common methods include comet assays, HR/NHEJ reporters, immunofluorescence foci, proteomics, RNA-seq and CRISPR screens.
How can CRISPR help study GO:2000779?
CRISPR knockout, point-mutation knock-in, tagged knock-in and overexpression models allow precise functional dissection of DSB repair regulators.
Conclusion
GO:2000779, regulation of double-strand break repair, is a central biological process that determines how cells respond to DNA breaks and whether repair is faithful or error-prone. Its regulation involves DNA end resection, ubiquitin and ubiquitin-like modifications, deubiquitinating enzymes, noncoding RNAs and mitotic kinases. Because deregulation of this process underlies cancer, neurodegeneration and genome instability, it remains a high-priority area for basic and translational research. CRISPR-based cell models and functional screens provide powerful tools to dissect the regulatory networks that define GO:2000779.
References
- 1. Symington LS et al.. 2011. Double-strand break end resection and repair pathway choice.. Annu Rev Genet 45:247-71 PMID: 21910633
- 2. Zastko L. 2025. Genetic Regulation of DNA Double-Strand Breaks and Repair Pathways.. Front Biosci (Schol Ed) 17(4):46225 PMID: 41504119
- 3. Hanscom T et al.. 2020. Regulation of Error-Prone DNA Double-Strand Break Repair and Its Impact on Genome Evolution.. Cells 9(7) PMID: 32660124
- 4. Shrivastav M et al.. 2008. Regulation of DNA double-strand break repair pathway choice.. Cell Res 18(1):134-47 PMID: 18157161
- 5. Li Y et al.. 2021. Role of deubiquitinating enzymes in DNA double-strand break repair.. J Zhejiang Univ Sci B 22(1):63-72 PMID: 33448188
- 6. Gelot C et al.. 2023. Polθ is phosphorylated by PLK1 to repair double-strand breaks in mitosis.. Nature 621(7978):415-422 PMID: 37674080
- 7. Durut N et al.. 2019. The Role of Noncoding RNAs in Double-Strand Break Repair.. Front Plant Sci 10:1155 PMID: 31611891
- 8. Schwertman P et al.. 2016. Regulation of DNA double-strand break repair by ubiquitin and ubiquitin-like modifiers.. Nat Rev Mol Cell Biol 17(6):379-94 PMID: 27211488
